HCV Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevir Treatment in Patients on Opioid Agonist Therapy: Co-STAR Part B

被引：0

作者：

Grebely, Jason ^{[1
]}

Litwin, Alain Harris ^{[2
]}

Dalgard, Olav ^{[3
]}

Gane, Edward J. ^{[4
]}

Shibolet, Oren ^{[5
,6
]}

Conway, Brian ^{[7
]}

Nahass, Ronald ^{[8
]}

Altice, Frederick ^{[9
]}

Luetkemeyer, Anne ^{[10
]}

Peng, Cheng-Yuan ^{[11
]}

Iser, David ^{[12
]}

Gendrano, Isaias Noel ^{[13
]}

Huang, Hsueh-Cheng ^{[13
]}

Kelly, Michelle M. ^{[13
]}

Hwang, Peggy ^{[13
]}

Barr, Eliav ^{[13
]}

Robertson, Michael Newton ^{[13
]}

Platt, Heather ^{[13
]}

Dore, Gregory ^{[1
]}

机构：

[1] Unsw Sydney, Kirby Inst, Sydney, NSW, Australia

[2] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA

[3] Akershus Univ, Inst Clin Med, Kjeller, Norway

[4] Auckland City Hosp, Auckland, New Zealand

[5] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel

[6] Tel Aviv Univ, Tel Aviv, Israel

[7] Vancouver Infect Dis Ctr, Vancouver, BC, Canada

[8] ID Care, Hillsborough, NJ USA

[9] Yale Univ, New Haven, CT 06520 USA

[10] Univ Calif San Francisco, San Francisco, CA 94143 USA

[11] China Med Univ Hosp, Taichung, Taiwan

[12] Alfred Hosp, Melbourne, Vic, Australia

[13] Merck & Co Inc, Kenilworth, NJ USA

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

下载

页码：35A / 35A

页数：1

共 12 条

[1] HCV reinfection and injecting risk behavior following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR Three Year Follow-up Study
Dore, Gregory
Grebely, Jason
Altice, Frederick
Litwin, Alain H.
Dalgard, Olav
Gane, Edward J.
Shibolet, Oren
Luetkemeyer, Anne
Nahass, Ronald
Peng, Cheng-Yuan
Conway, Brian
Iser, David M.
Huang, Hsueh-Cheng
Gendrano, Isaias N.
Kelly, Michelle M.
Hwang, Peggy
Robertson, Michael
Wahl, Janice
Barr, Eliav
Platt, Heather L.
HEPATOLOGY, 2016, 64 : 431A - 431A
[2] Hepatitis C Virus (HCV) Reinfection and Injecting Risk Behavior Following Elbasvir (EBR)/Grazoprevir (GZR) Treatment in Participants on Opiate Agonist Therapy (OAT): Co-STAR Part B
Dore, Gregory J.
Grebely, Jason
Altice, Frederick
Litwin, Alain H.
Dalgard, Olav
Gane, Edward J.
Shibolet, Oren
Conway, Brian
Nahass, Ronald
Luetkemeyer, Anne
Peng, Cheng-Yuan
Iser, David M.
Gendrano, Isaias N.
Kelly, Michelle M.
Huang, Hsueh-cheng
Hwang, Peggy
Barr, Eliav
Robertson, Michael
Platt, Heather
HEPATOLOGY, 2017, 66 : 112A - 113A
[3] DRUG USE AND REINFECTION DURING AND FOLLOWING HCV TREATMENT WITH ELBASVIR/GRAZOPREVIR AMONG PATIENTS RECEIVING OPIOID AGONIST THERAPY: FINAL RESULTS FROM THE CO-STAR STUDY
Grebely, Jason
Conway, Brian
Litwin, Alain H.
Dalgard, Olav
Shibolet, Oren
Nahass, Ronald G.
Altice, Frederick
Gane, Edward J.
Luetkemeyer, Annie
Peng, Cheng-Yuan
Iser, David
Gendrano, Isaias Noel, III
Kelly, Michelle
Hwang, Peggy
Asante-Appiah, Ernest
Barr, Eliav
Robertson, Michael Newton
Platt, Heather
Dore, Gregory
HEPATOLOGY, 2019, 70 : 955A - 956A
[4] HEPATITIS C VIRUS (HCV) REINFECTION AND INJECTION RISK BEHAVIOR FOLLOWING ELBASVIR/GRAZOPREVIR (EBR/GZR) TREATMENT IN PATIENTS ON OPIOID AGONIST THERAPY (OAT): CO-STAR THREE-YEAR FOLLOW-UP STUDY
Haber, Barbara
Gane, Edward
Dore, Gregory J.
Grebely, Jason
Altice, Frederick
Litwin, Alain H.
Dalgard, Olav
Shibolet, Oren
Luetkemeyer, Anne
Nahass, Ronald
Peng, Cheng-Yuan
Conway, Brian
Iser, David M.
Huang, Hsueh-Cheng
Gendrano, Isaias N.
Kelly, Michelle
Hwang, Peggy
Robertson, Michael
Wahl, Janice
Barr, Eliav
Platt, Heather L.
GASTROENTEROLOGY, 2017, 152 (05) : S1058 - S1059
[5] C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR AND GRAZOPREVIR IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT)
Dore, G.
Altice, F.
Litwin, A. H.
Grebely, J.
Dalgard, O.
Gane, E. J.
Shibolet, O.
Luetkemeyer, A.
Nahass, R.
Peng, C. -Y.
Conway, B.
Gendrano, I. N.
Huang, H. -C.
Chen, E.
Nguyen, B. -Y.
Wahl, J.
Barr, E.
Robertson, M.
Platt, H. L.
JOURNAL OF HEPATOLOGY, 2016, 64 : S771 - S771
[6] C-EDGE CO-STAR: Risk of reinfection following successful therapy with elbasvir and grazoprevir in persons who inject drugs (PWID) receiving opioid agonist therapy (OAT)
Dore, G. J.
Altice, F.
Litwin, A. H.
Grebely, J.
Dalgard, O.
Gane, E. J.
Shibolet, O.
Luetkemeyer, A.
Nahass, R.
Peng, C. Y.
Conway, B.
Gendrano, I. N.
Huang, H. C.
Chen, E.
Nguyen, B. Y.
Wahl, J.
Barr, E.
Robertson, R.
Platt, H. L.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 70 - 71
[7] C-EDGE CO-STAR: Efficacy of Grazoprevir and Elbasvir in Persons who Inject Drugs (PWID) Receiving Opioid Agonist Therapy
Dore, Gregory
Altice, Frederick
Litwin, Alain H.
Dalgard, Olav
Gane, Edward J.
Shibolet, Oren
Luetkemeyer, Anne
Nahass, Ronald
Peng, Cheng-Yuan
Conway, Brian
Grebely, Jason
Howe, Anita Y.
Nguyen, Bach-Yen T.
Wahl, Janice
Barr, Eliav
Robertson, Michael
Platt, Heather L.
HEPATOLOGY, 2015, 62 : 227A - 228A
[8] C-EDGE CO-STAR: FAVORABLE IMPACT OF ELBASVIR AND GRAZOPREVIR ON HEALTH-RELATED QUALITY OF LIFE IN TREATMENT-NAIVE HCV-INFECTED PERSONS WHO INJECT DRUGS RECEIVING OPIOID AGONIST THERAPY
Reeves, J. D.
Volpe, J.
Strommen, K.
Anton, E.
Martens, S.
Yang, D.
Whitcomb, J.
Huang, W.
Petropoulos, C. J.
Walworth, C.
JOURNAL OF HEPATOLOGY, 2016, 64 : S403 - S403
[9] C-EDGE CO-STAR: FAVORABLE IMPACT OF ELBASVIR AND GRAZOPREVIR ON HEALTH-RELATED QUALITY OF LIFE IN TREATMENT-NAIVE HCV-INFECTED PERSONS WHO INJECT DRUGS RECEIVING OPIOID AGONIST THERAPY
Arduino, J. M.
Shibolet, O.
Litwin, A. H.
Grebeley, J.
Altice, F.
Nwankwo, C.
Mast, T. C.
Jiang, Z.
Gendrano, I. N.
Platt, H. L.
Dore, G. J.
JOURNAL OF HEPATOLOGY, 2016, 64 : S403 - S404
[10] EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFFECTION WHO RECEIVE OPIOID AGONIST THERAPY: TREATMENT UTILIZATION AND THE IMPACT OF CONCOMITANT PSYCHIATRIC MEDICATIONS
Kramer, Jennifer R.
Puenpatom, Amy
Cao, Yumei
El-Serag, Hashem B.
Kanwal, Fasiha
GASTROENTEROLOGY, 2019, 156 (06) : S1219 - S1219

← 1 2 →